Friday - November 22, 2019
Abbott Laboratories, Icahn School of Medicine at Mount Sinai Assigned Patent for Detection Methods Employing HCV Core Lipid
Copyright © Targeted News Service, 2019
2019-10-19
ALEXANDRIA, Va., Oct. 19 -- Abbott Laboratories, Abbott Park, Illinois, and Icahn School of Medicine at Mount Sinai, New York, have been assigned a patent (No. 10,444,242, initially filed June 22, 2016) developed by nine co-inventors for "detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies." The co-inventors are Robert Ziemann, Abbott Park, Illinois, April Ahlberg, Abbott Park, Illinois, David Hawksworth, Abbott Park, Illinois, Bryan Tieman, Abbott Park, Illin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2019